The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity
暂无分享,去创建一个
Matthew V. Holt | J. Qin | K. Guan | Wei-Wei Pan | D. Carson | Tomoko Hayashi | Y. Fujita | T. Moroishi
[1] N. Silverman,et al. Toll Receptor-Mediated Hippo Signaling Controls Innate Immunity in Drosophila , 2016, Cell.
[2] Xin-hua Liang,et al. Immunocompromised and immunocompetent mouse models for head and neck squamous cell carcinoma , 2016, OncoTargets and therapy.
[3] Kun-Liang Guan,et al. Mechanisms of Hippo pathway regulation , 2016, Genes & development.
[4] E. Wagner,et al. Chronic inflammation imposes aberrant cell fate in regenerating epithelia through mechanotransduction , 2015, Nature Cell Biology.
[5] Bin Zhao,et al. Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer , 2015, Cell.
[6] N. Tapon,et al. The Hippo Pathway Core Cassette Regulates Asymmetric Cell Division , 2015, Current Biology.
[7] C. A. Johnston,et al. Warts Phosphorylates Mud to Promote Pins-Mediated Mitotic Spindle Orientation in Drosophila, Independent of Yorkie , 2015, Current Biology.
[8] G. Halder,et al. MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway , 2015, Nature Communications.
[9] K. Guan,et al. YAP and TAZ: a nexus for Hippo signaling and beyond. , 2015, Trends in cell biology.
[10] M. Beckmann,et al. Abstract B32: Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses , 2016 .
[11] T. Junt,et al. Translating nucleic acid-sensing pathways into therapies , 2015, Nature Reviews Immunology.
[12] R. Kiessling,et al. Checkpoint blockade for cancer therapy: revitalizing a suppressed immune system. , 2015, Trends in molecular medicine.
[13] M. Karin,et al. A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis , 2015, Genes & development.
[14] P. Sharma,et al. Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential , 2015, Cell.
[15] John T. Chang,et al. A gp130–Src–YAP module links inflammation to epithelial regeneration , 2015, Nature.
[16] Kun-Liang Guan,et al. The emerging roles of YAP and TAZ in cancer , 2015, Nature Reviews Cancer.
[17] L. O’Driscoll,et al. Biological properties of extracellular vesicles and their physiological functions , 2015, Journal of extracellular vesicles.
[18] M. Delorenzi,et al. Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy , 2014, Nature Medicine.
[19] G. Tonon,et al. RESCUE OF HIPPO CO-ACTIVATOR YAP1 TRIGGERS DNA DAMAGE-INDUCED APOPTOSIS IN HEMATOLOGICAL CANCERS , 2014, Nature Medicine.
[20] F. Camargo,et al. Hippo Signaling Regulates Microprocessor and Links Cell-Density-Dependent miRNA Biogenesis to Cancer , 2014, Cell.
[21] P. Robbins,et al. Regulation of immune responses by extracellular vesicles , 2014, Nature Reviews Immunology.
[22] G. Halder,et al. Discovering the Hippo pathway protein-protein interactome , 2014, Cell Research.
[23] G. Halder,et al. The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment , 2013, Nature Reviews Drug Discovery.
[24] Feng Zhang,et al. Genome engineering using CRISPR-Cas9 system. , 2015, Methods in molecular biology.
[25] H. Schreiber,et al. Innate and adaptive immune cells in the tumor microenvironment , 2013, Nature Immunology.
[26] Anushya Muruganujan,et al. Large-scale gene function analysis with the PANTHER classification system , 2013, Nature Protocols.
[27] David M. Thomas,et al. The Hippo pathway and human cancer , 2013, Nature Reviews Cancer.
[28] yang-xin fu,et al. Type I interferon response and innate immune sensing of cancer. , 2013, Trends in immunology.
[29] Shuji Ogino,et al. Restriction of intestinal stem cell expansion and the regenerative response by YAP , 2012, Nature.
[30] Ming Li,et al. An Immunosurveillance Mechanism Controls Cancer Cell Ploidy , 2012, Science.
[31] Prahlad T. Ram,et al. NetWalker: a contextual network analysis tool for functional genomics , 2012, BMC Genomics.
[32] G. Dranoff,et al. Experimental mouse tumour models: what can be learnt about human cancer immunology? , 2011, Nature Reviews Immunology.
[33] M. Selbach,et al. Global quantification of mammalian gene expression control , 2011, Nature.
[34] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[35] Jeannie T. Lee,et al. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. , 2009, Cancer cell.
[36] Kenta Nakai,et al. PrognoScan: a new database for meta-analysis of the prognostic value of genes , 2009, BMC Medical Genomics.
[37] Jiandie D. Lin,et al. TEAD mediates YAP-dependent gene induction and growth control. , 2008, Genes & development.
[38] R. Jaenisch,et al. YAP1 Increases Organ Size and Expands Undifferentiated Progenitor Cells , 2007, Current Biology.
[39] Li Li,et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. , 2007, Genes & development.
[40] G. Feldmann,et al. Elucidation of a Universal Size-Control Mechanism in Drosophila and Mammals , 2007, Cell.
[41] Hong Liu,et al. The dual functions of YAP-1 to promote and inhibit cell growth in human malignancy , 2013, Cancer and Metastasis Reviews.